Vimarsana
Biggest News Aggregation in the World

Novel Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novel Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novel Pathways Today - Breaking & Trending Today

Arrowhead Presents New Phase 2 Data on Plozasiran and Zodasiran at AHA 2023 - Vimarsana News

Arrowhead Presents New Phase 2 Data on Plozasiran and Zodasiran at AHA 2023

- Plozasiran achieved mean max reductions of up to 90% in APOC3 and 87% in triglycerides in patients with severe hypertriglyceridemia - In patients with mixed dyslipidemia, mean max reduction in...

AI-Powered Method Revolutionizes Analysis of 2D Materials - Vimarsana News

AI-Powered Method Revolutionizes Analysis of 2D Materials

Two-dimensional (2D) materials-materials just a few atoms thick-can have special properties due to quantum mechanics.

Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023 - Vimarsana News

Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023

- Company will also host a virtual analyst and investor event on November 13, 2023 ...

CymaBay Therapeutics Presents Data Showing Seladelpar Treatment in Primary Biliary Cholangitis (PBC) Correlates with Alleviation of Self-Reported Pruritus and Reduction in Serum IL-31 Levels - Vimarsana News

CymaBay Therapeutics Presents Data Showing Seladelpar Treatment in Primary Biliary Cholangitis (PBC) Correlates with Alleviation of Self-Reported Pruritus and Reduction in Serum IL-31 Levels

Additional data presented at The International Liver Congress™ 2023 show clinical risk factors for PBC disease progression present in a broader population of UDCA-treated PBC... | June 21, 2023

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript - Vimarsana News

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.